Jianyong Li, MD, PhD

Chief of Hematology department
Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Nanjing, China (People's Republic)

N/A

Presentation(s):

• (1538890) m6A-modified circTET2 interacting with HNRNPC regulates fatty acid oxidation to promote the proliferation of chronic lymphocytic leukemia

  Friday, October 6, 2023
  8:55 AM – 9:00 AM EDT

• (1550959) Integrating Multi-Omics to Reveal the Heterogeneous Clonal Evolutionary Characteristics in CLL Patients with Zanubrutinib Resistance

  Friday, October 6, 2023
  11:10 AM – 11:15 AM EDT

• (1551047) Single-cell RNA sequencing Reveals the Spatial Heterogeneity in BTKi-Resistant Richter Transformation Patients

  Friday, October 6, 2023
  11:15 AM – 11:20 AM EDT

• (1551507) Single center report on cohort of patients relapsed on Bruton Tyrosine Kinase inhibitors (BTKi)

  Friday, October 6, 2023
  1:20 PM – 1:30 PM EDT

• (1553010) Bruton tyrosine kinase inhibitor ibrutinib induces hypertension by upregulating transcription of CaV1.2 calcium channel

  Sunday, October 8, 2023
  9:35 AM – 9:45 AM EDT

• (1550584) A high proportion of IGHV4-39, subset#8 and #8B in Chinese patients with chronic lymphocytic leukemia: a retrospective analysis of 3154 Ig VH sequences by cwCLL, Chinese workshop on CLL

  Monday, October 9, 2023
  3:00 PM – 3:10 PM EDT